静脈内輸液ポンプの世界市場

静脈内輸液ポンプの世界市場は2030年までに85億米ドルに達する見込み

2024年に60億米ドルと推定される静脈内輸液ポンプの世界市場は、2024年から2030年にかけてCAGR 5.8%で成長し、2030年には85億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである容量型輸液ポンプは、CAGR 5.1％を記録し、分析期間終了時には25億米ドルに達すると予測されます。インスリン注入ポンプ分野の成長率は、分析期間中CAGR 5.0％と推定されます。

米国市場は16億米ドル、中国はCAGR9.0％で成長予測

米国の静脈内輸液ポンプ市場は2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに17億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.7%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の静脈内輸液ポンプ市場- 主要動向と促進要因のまとめ

静脈内輸液ポンプはどのように患者ケアを変革しているか？

静脈内輸液ポンプ市場は、高精度な薬物送達、ヘルスケアの自動化、輸液技術の進歩に対する需要の高まりにより、大きな成長を遂げています。静脈内輸液ポンプは、輸液、薬物、栄養素を制御された量で患者の血流に直接送り込むために使用される重要な医療機器です。病院、外来手術センター、在宅医療、集中治療室（ICU）などで、持続的な薬物注入、化学療法、疼痛管理、水分補給療法が必要な場合に重要な役割を果たしています。

糖尿病、がん、心血管障害などの慢性疾患の有病率の上昇に伴い、静脈内輸液ポンプは長期的な患者管理に不可欠なものとなっています。さらに、スマート輸液ポンプ、ワイヤレス接続、AIによる投与量調整などの技術革新は、病院のワークフロー、患者の安全性、薬剤投与の正確性に革命をもたらしています。

COVID-19の大流行は静脈内輸液ポンプの採用をさらに加速させ、病院は看護師の作業負担を最小限に抑え、感染管理を強化し、ICU環境における患者管理を最適化するための自動化された遠隔監視輸液システムに対する需要の高まりに直面しました。ヘルスケアプロバイダーが引き続き自動化、患者の安全性、デジタルヘルスシステムとの統合を優先しているため、輸液ポンプ市場は今後数年で急成長すると予想されます。

輸液ポンプ市場を牽引する主要動向とは？

輸液ポンプ市場で最も変革的な動向の1つは、スマート輸液ポンプの台頭です。これらのAI駆動でプログラム可能な輸液システムには、投与エラー削減システム（DERS）、リアルタイムの薬剤ライブラリ、ワイヤレス接続が付属しており、人的ミスを減らしながら正確な薬剤投与を保証します。スマートポンプは、電子カルテ（EHR）や臨床意思決定支援システム（CDSS）との統合が進んでおり、ワークフローの自動化を改善し、投薬の最適化を図っています。

もう1つの大きな動向は、在宅治療のための外来用輸液ポンプの採用が増加していることです。在宅ヘルスケアや外来治療が普及するにつれ、慢性疾患管理、化学療法、疼痛緩和治療などに、軽量で持ち運び可能な装着型輸液ポンプが使用されるようになっています。この動向は、従来の病院以外の場所で治療を受ける、個別化された患者中心の治療モデルへのシフトと一致しています。

無線モニタリングとIoT対応輸液ポンプの統合もまた、業界に革命をもたらしています。最新の輸液ポンプは、病院ネットワークやクラウドベースのプラットフォームにリアルタイムでデータを送信し、輸液速度の遠隔監視、投与量の不一致の早期発見、メンテナンスの予知アラートを可能にします。この技術は患者の安全性を高め、看護師の負担を軽減し、投薬ミスを最小限に抑えます。

さらに、ロボット支援輸液ポンプやAIを活用した投与アルゴリズムが開発され、薬剤投与の精度を向上させ、過剰投与のリスクを防止しています。AIを活用した輸液システムは、患者のバイタル、薬物相互作用、過去の投与パターンを分析し、特にクリティカルケアや麻酔管理において輸液速度を動的に調整します。

もう一つの新たな動向は、使い捨てや針を使わない輸液システムの開発です。感染管理、交差汚染、針刺し傷害に対する懸念から、メーカーは特に腫瘍学、免疫療法、新生児ケアの用途で、シングルユースやクローズドシステムの輸液ポンプを導入しています。これらの技術革新は、病院の安全プロトコルや感染予防ガイドラインに沿ったものです。

輸液ポンプ市場に影響を与える課題とは？

静脈内注入技術の急速な進歩にもかかわらず、同市場は機器コストの高さ、メンテナンスの複雑さ、規制上のハードルなど、いくつかの課題に直面しています。最大の懸念は、スマート輸液ポンプや高度ドラッグデリバリーシステムのコストが高いことです。これらの機器は精度と安全性を高める一方で、病院のインフラ、トレーニング、サイバーセキュリティに多額の投資を必要とするため、中小規模の医療施設では導入が難しいです。

もう一つの重要な課題は、輸液ポンプのエラーや機器の故障です。プログラミング・エラー、機械的な故障、ソフトウェアの不具合により、重大な投薬ミス、過剰投与、投与量不足の事故が発生し、製品回収や規制当局の監視につながっています。FDAやその他の保健機関は輸液ポンプの誤作動に関する安全警告を発し、メーカーに品質管理、エラー防止アルゴリズム、ユーザートレーニングの改善を促しています。

IoT対応でワイヤレスの輸液ポンプが一般的になるにつれ、サイバーセキュリティの脅威とデータの脆弱性が別の課題となっています。病院ネットワークを狙うハッカーが輸液速度を操作したり、患者データを漏洩させたりする可能性があり、深刻な健康リスクや責任問題につながります。ヘルスケア施設は、強固なサイバーセキュリティ・プロトコル、暗号化技術、定期的なソフトウェア・アップデートを導入し、輸液デバイスへのサイバー攻撃の可能性を防止する必要があります。

機器の相互運用性や病院ITシステムとの統合が複雑であることも、導入の妨げとなっています。多くの病院ではいまだに旧式の電子カルテ（EHR）システムを使用しているため、スマート輸液ポンプを既存のインフラとシームレスに統合することが困難です。異なるヘルスケアプラットフォーム間でのスムーズなデータ交換と互換性を確保するためには、標準化の取り組みが必要です。

さらに、規制当局の承認やコンプライアンス要件が厳しいため、輸液ポンプの新モデルの導入が遅れています。輸液ポンプは、安全性、投与量精度、ソフトウェアの信頼性に関する厳格なFDA、CE（欧州）、ISO（国際標準化機構）のガイドラインを満たす必要があります。承認プロセスに時間がかかるため、革新的な輸液デバイスの研究開発コストと市場投入までの時間が増大します。

静脈内注入ポンプ市場の成長を促進する要因は？

輸液ポンプ市場の成長は、慢性疾患の有病率の上昇、医療技術の進歩、薬物デリバリーの自動化に対する需要の高まりなど、いくつかの要因によってもたらされます。最大の促進要因の1つは、特にクリティカルケア、腫瘍学、新生児医療において、正確かつ制御された薬剤投与の必要性が高まっていることです。安全機構を備えたスマート輸液ポンプは、投薬ミスを減らすのに役立ち、ICU、手術室、小児病棟などのリスクの高い環境では不可欠となっています。

在宅輸液療法や外来輸液療法の採用が増加していることも大きな推進力となっています。糖尿病、がん、自己免疫疾患などの慢性疾患の患者は、長期の輸液療法を必要とすることが多いため、病院外での治療を可能にする携帯型・装着型の輸液ポンプの需要が高まっています。高齢者人口の増加と遠隔医療サービスの台頭が、この動向をさらに後押ししています。

非経口栄養や疼痛管理ソリューションに対する需要の高まりも、市場の成長を後押ししています。栄養不良、胃腸障害、術後の回復に苦しむ患者は、輸液ポンプによる静脈栄養を必要とするため、特殊な経腸・非経口輸液装置の需要が高まっています。同様に、患者制御鎮痛（PCA）ポンプは、術後や緩和ケアにおけるオピオイドを使用しない疼痛管理のために人気を集めています。

新興市場における政府の取り組みやヘルスケアインフラの近代化プロジェクトも、市場拡大に拍車をかけています。アジア太平洋、ラテンアメリカ、中東の各国は、患者ケアの強化と院内合併症の減少を目的として、先進的な病院設備、デジタルヘルスソリューション、スマート輸液システムに投資しています。

さらに、個別化医療とドラッグデリバリーの台頭は、遺伝子治療、免疫療法、標的がん治療用に設計された特殊輸液システムの需要を促進しています。複雑な生物学的製剤のパイプラインの増加に伴い、製薬会社は医療機器メーカーと提携し、精密な薬剤投与のための次世代輸液技術を開発しています。

結論輸液ポンプ技術の将来

ヘルスケア施設、在宅ケアプロバイダー、製薬会社がよりスマートで安全、かつ効率的なドラッグデリバリーシステムを採用するにつれ、輸液ポンプ市場は継続的な成長を遂げる見込みです。AI、ロボット工学、デジタルヘルス統合の技術革新が進む中、輸液ポンプは個別化医療、自動薬剤投与、遠隔患者モニタリングにおいてますます重要な役割を果たすようになるでしょう。

デバイスの安全性、サイバーセキュリティ、規制順守、シームレスな病院との統合を優先するメーカーは、進化する輸液療法の状況において競争優位に立つでしょう。精密ベース、低侵襲、コネクテッド輸液システムに対する需要が高まる中、輸液療法の将来は自動化、患者中心のソリューション、高度なデジタルヘルスエコシステムによって定義されるでしょう。

セグメント

製品（容量輸液ポンプ、インスリン輸液ポンプ、シリンジ輸液ポンプ、経腸輸液ポンプ、外来輸液ポンプ、患者制御鎮痛、埋め込み型輸液ポンプ、その他）、適応疾患（化学療法、糖尿病、消化器病、鎮痛／疼痛管理、小児科／新生児科、血液内科、その他）

調査対象企業の例

• Alaris（part of BD）
• Autoinfu
• B. Braun Infusomat
• B. Braun Melsungen AG
• Baxter International
• Baxter Sigma Spectrum
• BD（Becton, Dickinson and Company）
• Biomedix Medical, Inc.
• DiaMedical USA
• Fresenius Kabi
• ICU Medical
• IRadimed Corporation
• Med One Group
• Medtronic plc
• Moog Inc.
• Moog Medical Devices Group
• Smiths Medical
• Terumo Corporation
• Zyno Medical

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Intravenous Infusion Pumps Market to Reach US$8.5 Billion by 2030

The global market for Intravenous Infusion Pumps estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Insulin Infusion Pumps segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.0% CAGR

The Intravenous Infusion Pumps market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Intravenous Infusion Pump Market - Key Trends & Drivers Summarized

How Are Intravenous Infusion Pumps Transforming Patient Care?

The intravenous (IV) infusion pump market is experiencing significant growth due to the increasing demand for precision drug delivery, automation in healthcare, and advancements in infusion technology. IV infusion pumps are critical medical devices used to deliver fluids, medications, and nutrients directly into a patient’s bloodstream in controlled amounts. They play a vital role in hospitals, ambulatory surgical centers, home healthcare, and intensive care units (ICUs) for conditions requiring continuous drug infusion, chemotherapy, pain management, and hydration therapy.

With the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, IV infusion pumps have become essential for long-term patient management. Additionally, technological innovations such as smart infusion pumps, wireless connectivity, and AI-driven dosage adjustments are revolutionizing hospital workflows, patient safety, and drug administration accuracy.

The COVID-19 pandemic further accelerated the adoption of IV infusion pumps, as hospitals faced an increased demand for automated and remotely monitored infusion systems to minimize nurse workload, enhance infection control, and optimize patient management in ICU settings. As healthcare providers continue to prioritize automation, patient safety, and integration with digital health systems, the IV infusion pump market is expected to grow rapidly in the coming years.

What Are the Key Trends Driving the IV Infusion Pump Market?

One of the most transformative trends in the IV infusion pump market is the rise of smart infusion pumps. These AI-driven and programmable infusion systems come with dose error reduction systems (DERS), real-time drug libraries, and wireless connectivity, ensuring precise medication administration while reducing human errors. Smart pumps are increasingly being integrated with electronic health records (EHRs) and clinical decision support systems (CDSS) to improve workflow automation and optimize medication dosing.

Another major trend is the increasing adoption of ambulatory infusion pumps for home-based therapy. As home healthcare and outpatient treatment gain popularity, lightweight, portable, and wearable infusion pumps are being used for chronic disease management, chemotherapy, and pain relief treatments. This trend aligns with the shift toward personalized and patient-centric care models, where individuals receive treatment outside of traditional hospital settings.

The integration of wireless monitoring and IoT-enabled infusion pumps is also revolutionizing the industry. Modern IV infusion pumps transmit real-time data to hospital networks and cloud-based platforms, allowing remote monitoring of infusion rates, early detection of dosage discrepancies, and predictive maintenance alerts. This technology enhances patient safety, reduces nurse workload, and minimizes medication errors.

Additionally, robotic-assisted infusion pumps and AI-powered dosing algorithms are being developed to improve drug administration accuracy and prevent overdose risks. AI-driven infusion systems analyze patient vitals, drug interactions, and historical dosage patterns to adjust infusion rates dynamically, particularly in critical care and anesthesia management.

Another emerging trend is the development of disposable and needle-free infusion systems. Concerns over infection control, cross-contamination, and needle-stick injuries have driven manufacturers to introduce single-use and closed-system infusion pumps, particularly for oncology, immunotherapy, and neonatal care applications. These innovations align with hospital safety protocols and infection prevention guidelines.

What Challenges Are Impacting the IV Infusion Pump Market?

Despite the rapid advancements in IV infusion technology, the market faces several challenges, including high device costs, maintenance complexity, and regulatory hurdles. One of the biggest concerns is the high cost of smart infusion pumps and advanced drug delivery systems. While these devices enhance accuracy and safety, they require significant investment in hospital infrastructure, training, and cybersecurity, making adoption difficult for small and mid-sized healthcare facilities.

Another key challenge is infusion pump errors and device malfunctions. Programming errors, mechanical failures, and software glitches have resulted in serious medication errors, overdoses, and under-dosing incidents, leading to product recalls and regulatory scrutiny. The FDA and other health agencies have issued safety alerts regarding infusion pump malfunctions, prompting manufacturers to improve quality control, error prevention algorithms, and user training.

Cybersecurity threats and data vulnerabilities pose another challenge, as IoT-enabled and wireless infusion pumps become more common. Hackers targeting hospital networks could manipulate infusion rates or compromise patient data, leading to serious health risks and liability concerns. Healthcare facilities must implement robust cybersecurity protocols, encryption technologies, and regular software updates to prevent potential cyberattacks on infusion devices.

Complexity in device interoperability and integration with hospital IT systems also hinders adoption. Many hospitals still operate with legacy electronic health record (EHR) systems, making it difficult to seamlessly integrate smart IV pumps with existing infrastructure. Standardization efforts are needed to ensure smooth data exchange and compatibility across different healthcare platforms.

Additionally, stringent regulatory approvals and compliance requirements delay the introduction of new infusion pump models. IV infusion pumps must meet strict FDA, CE (Europe), and ISO (International Organization for Standardization) guidelines regarding safety, dosage accuracy, and software reliability. The lengthy approval process increases R&D costs and time-to-market for innovative infusion devices.

What Factors Are Driving the Growth of the IV Infusion Pump Market?

The growth in the IV infusion pump market is driven by several factors, including the rising prevalence of chronic diseases, advancements in medical technology, and increasing demand for automation in drug delivery. One of the biggest drivers is the growing need for precise and controlled medication administration, particularly in critical care, oncology, and neonatal care. Smart infusion pumps equipped with safety mechanisms help reduce medication errors, making them essential in high-risk environments such as ICUs, operating rooms, and pediatric wards.

Another major driver is the increasing adoption of home-based and ambulatory infusion therapy. Patients with chronic conditions such as diabetes, cancer, and autoimmune disorders often require long-term infusion therapy, leading to the rising demand for portable and wearable IV pumps that enable treatment outside hospital settings. The growing elderly population and the rise of telehealth services further support this trend.

The increasing demand for parenteral nutrition and pain management solutions is also propelling market growth. Patients suffering from malnutrition, gastrointestinal disorders, or post-operative recovery require intravenous feeding via infusion pumps, driving demand for specialized enteral and parenteral infusion devices. Similarly, patient-controlled analgesia (PCA) pumps are gaining popularity for opioid-free pain management in post-surgical and palliative care.

Government initiatives and healthcare infrastructure modernization projects in emerging markets are also fueling market expansion. Countries across Asia-Pacific, Latin America, and the Middle East are investing in advanced hospital equipment, digital health solutions, and smart infusion systems to enhance patient care and reduce hospital-acquired complications.

Furthermore, the rise of personalized medicine and biologic drug delivery is driving demand for specialized infusion systems designed for gene therapy, immunotherapy, and targeted cancer treatments. With the growing pipeline of complex biologic drugs, pharmaceutical companies are partnering with medical device manufacturers to develop next-generation infusion technologies for precision drug administration.

Conclusion: The Future of IV Infusion Pump Technology

The IV infusion pump market is poised for continued growth as healthcare facilities, home-based care providers, and pharmaceutical companies adopt smarter, safer, and more efficient drug delivery systems. With ongoing innovations in AI, robotics, and digital health integration, IV pumps will play an increasingly critical role in personalized medicine, automated drug administration, and remote patient monitoring.

Manufacturers that prioritize device safety, cybersecurity, regulatory compliance, and seamless hospital integration will gain a competitive edge in the evolving infusion therapy landscape. As demand for precision-based, minimally invasive, and connected infusion systems rises, the future of IV therapy will be defined by automation, patient-centric solutions, and advanced digital health ecosystems.

SCOPE OF STUDY:

The report analyzes the Intravenous Infusion Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps, Others); Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Alaris (part of BD)
• Autoinfu
• B. Braun Infusomat
• B. Braun Melsungen AG
• Baxter International
• Baxter Sigma Spectrum
• BD (Becton, Dickinson and Company)
• Biomedix Medical, Inc.
• DiaMedical USA
• Fresenius Kabi
• ICU Medical
• IRadimed Corporation
• Med One Group
• Medtronic plc
• Moog Inc.
• Moog Medical Devices Group
• Smiths Medical
• Terumo Corporation
• Zyno Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Intravenous Infusion Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Hospitalization Rates and Critical Care Admissions Drive Demand for Intravenous Infusion Pumps
  • Increasing Prevalence of Chronic Diseases and Long-Term Therapies Expands Use of Infusion Pumps in Homecare
  • Growth in Geriatric Population Sustains Demand for Continuous and Controlled Drug Delivery Systems
  • Technological Advancements in Smart Pumps Enhance Safety, Monitoring, and Drug Delivery Precision
  • Integration With EMR and Medication Management Systems Strengthens the Business Case for Smart Infusion Devices
  • Growing Incidence of Medication Errors Spurs Adoption of Dose Error Reduction Systems (DERS) in Infusion Pumps
  • Expansion of Ambulatory and Day-Care Procedures Fuels Demand for Portable and Wearable Infusion Pumps
  • Surge in Chemotherapy, Parenteral Nutrition, and Pain Management Therapies Drives Use in Specialty Care
  • Adoption of Wireless Connectivity and Remote Monitoring Features Creates Differentiation in High-Acuity Settings
  • Increased Investment in Hospital Automation and Digital Infrastructure Propels Infusion System Modernization
  • High Demand for Battery-Powered and Multi-Channel Pumps Enhances Versatility Across Care Settings
  • Growing Focus on Patient-Centric Care Models Drives Development of User-Friendly and Intuitive Pump Interfaces
  • Regulatory Emphasis on Infusion Pump Safety and Post-Market Surveillance Strengthens Product Quality Standards
  • Emergence of Closed-Loop and Autonomous Infusion Technologies Drives R&D Innovation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Intravenous Infusion Pumps Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Volumetric Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Insulin Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Syringe Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Enteral Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Patient Controlled Analgesia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Implantable Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Analgesia / Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Pediatrics / Neonatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• JAPAN
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• CHINA
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• EUROPE
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• FRANCE
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• GERMANY
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: UK 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 107: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Spain Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Spain 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Spain 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 113: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Russia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Russia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 116: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Russia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Russia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Rest of Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Rest of Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 134: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Australia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Australia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 137: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Australia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Australia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• INDIA
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 140: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: India Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: India 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 143: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: India Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: India 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 146: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: South Korea Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 149: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: South Korea Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Latin America Historic Review for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 161: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 164: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 167: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Argentina Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 170: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Argentina Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 173: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Brazil Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 176: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Brazil Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 179: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Mexico Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 182: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Mexico Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 191: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Middle East Historic Review for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 194: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 197: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 200: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Iran Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Iran 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 203: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Iran Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Iran 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 206: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Israel Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Israel 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 209: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Israel Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Israel 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 215: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 218: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: UAE Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: UAE 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 221: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: UAE Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: UAE 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 227: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
• AFRICA
  • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 230: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Africa Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Africa 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
  • TABLE 233: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Africa Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Africa 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030

IV. COMPETITION